The film 'Dallas Buyers Club' brought the medical world into stark relief, and not in a good way, so it is only natural that similar start-ups like myTomorrows would emerge. myTomorrows, however, plays it safer than Ron Woodroof did. Founded by Ronald Brus, it works "with drug companies to get not-yet-approved treatments stuck in regulatory purgatory to patients—giving them one last chance to survive," writes Fast Co Exist.
myTomorrows was inspired when Brus' father was diagnosed with a serious, difficult to treat lung cancer. Although only operating in Turkey and Europe for now, myTomorrows has managed to help hundreds of patients and hopes to help hundreds more. Brus says, "It can take 15 years for a drug to be approved, but maybe after eight years, there’s pretty good evidence that a drug does work or doesn’t work. We believe it’s unethical not to give the patients that drug."
Experimental Drug Start-Ups
Ronald Brus' myTomorrows is the Latest Take on the Dallas Buyers Club
Trend Themes
1. Experimental Drug Start-ups - Start-ups focusing on providing experimental drug treatments to patients stuck in regulatory purgatory.
2. Personalized Medicine - The emergence of businesses aiming to improve treatments for serious diseases by developing personalized medicine.
3. Direct-to-consumer Healthcare - Companies working to bring drugs that are stuck in regulatory limbo directly to consumers through online platforms.
Industry Implications
1. Pharmaceuticals - Opportunity for pharmaceutical companies to expand their operations and partner with companies like myTomorrows to get their treatments to market and reach more patients.
2. Healthcare - Opportunity for healthcare providers to expand their treatment options and improve patient outcomes by collaborating with companies like myTomorrows and exploring personalized medicine solutions.
3. E-commerce - Opportunity for e-commerce platforms to disrupt the way drugs are distributed, by partnering with companies like myTomorrows and providing direct-to-consumer access to drug treatments.